Superworth

Propanc Biopharma market cap PPCB

Share price times shares outstanding: what the whole company sells for, since 2012.

Today, Oct 23, 2026
$1.8M
Highest close in our data
$111.5M
Aug 2025

Propanc Biopharma is worth $1.8M at the close on Oct 23, 2026, at $0.28 a share.

That is down 91% over the last year and up 4431680% over five years.

Its highest close in our data was $111.5M in Aug 2025.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$1.8M$1.4M$7.6M−77%
2025$7.8M$34.6K$111.5M+4857%
2024$158K$41.7K$319.2K−41%
2023$267.3K$7$1.2M+1485067%
2022$18$6$480.8K−75%
2021$73$5$73+1117%
2020$6$2$51+20%
2019$5$5$168−97%
2018$143$5$459+198%
2017$48$21$375−79%
2016$233$165$774−37%
2015$369$4$1.1K+5171%
2014$7$4$339−97%
2013$242$1$242+24100%
2012$1$1$2n/a

Against its peers

Companies in Healthcare nearest Propanc Biopharma's size, closest first, today.

CompanyMarket cap
PPCBPropanc Biopharma$1.8M
OXBROXBRIDGE RE HOLDINGS$7.7M
EDUCEducational Development$8.7M
GTIMGood Times Restaurants$13.6M
MDRRMedalist Diversified$15.4M
Peer median$11.2M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Propanc Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.